KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Diversified Healthcare Trust (DHC) Asset Writedowns and Impairment (2016 - 2025)

Diversified Healthcare Trust (DHC) has disclosed Asset Writedowns and Impairment for 15 consecutive years, with $3.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Asset Writedowns and Impairment fell 89.68% year-over-year to $3.0 million, compared with a TTM value of $165.7 million through Dec 2025, up 134.26%, and an annual FY2025 reading of $165.7 million, up 134.26% over the prior year.
  • Asset Writedowns and Impairment was $3.0 million for Q4 2025 at Diversified Healthcare Trust, down from $93.2 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $93.2 million in Q3 2025 and bottomed at -$174000.0 in Q1 2021.
  • Average Asset Writedowns and Impairment over 4 years is $21.2 million, with a median of $11.7 million recorded in 2023.
  • The sharpest move saw Asset Writedowns and Impairment soared 1892.3% in 2024, then plummeted 89.68% in 2025.
  • Year by year, Asset Writedowns and Impairment stood at -$174000.0 in 2021, then surged by 764.37% to $1.2 million in 2023, then skyrocketed by 2410.03% to $29.0 million in 2024, then tumbled by 89.68% to $3.0 million in 2025.
  • Business Quant data shows Asset Writedowns and Impairment for DHC at $3.0 million in Q4 2025, $93.2 million in Q3 2025, and $31.0 million in Q2 2025.